Screening for congenital toxoplasmosis: Accuracy of immunoglobulin M and immunoglobulin A tests after birth

Journal of Medical Screening

Volumn 14, Issue 1, 2007, Pages 8-13

  Gilbert, Ruth E ^a   Thalib, Lukman ^b   Hooi, Kuan Tan ^a   Paul, Margaret ^c   Wallon, Martine ^d   Petersen, Eskild ^e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KUWAIT UNIVERSITY   (Kuwait)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d CROIX ROUSSE HOSPITAL   (France)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; PYRIMETHAMINE; SPIRAMYCIN; SULFONAMIDE;

AGGLUTINATION TEST; ARTICLE; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; INFANT; MAJOR CLINICAL STUDY; NEWBORN SCREENING; SCREENING TEST; SEROCONVERSION;

ALGORITHMS; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INFANT, NEWBORN; NEONATAL SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TIME FACTORS; TOXOPLASMOSIS, CONGENITAL;

EID: 33947303499     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/096914107780154440     Document Type: Article

References (40)

1. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis In: Remington JS, Klein J, eds. Infectious Diseases of the Fetus and Newborn Infant. 5th edn. Philadelphia: WB Saunders, 2001;205-346
2. Thiebaut R, Leproust S, Chene G, Gilbert RE, The SYROCOT Study Group. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 2007;369:115-22
3. Binquet C, Wallon M, Quantin C, et al. Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol Infect 2003;131:1157-68
4. Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group (see comments). N Engl J Med 1994;330:1858-63
5. Lebech M, Andersen O, Christensen NC, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 1999;353:1834-7
6. Neto EC, Anele E, Rubim R, et al. High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. Int J Epidemiol 2000;29:941-7
7. Paul M, Petersen E, Pawlowski ZS, Szczapa J. Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J 2000;19:30-6
8. Paul M, Petersen E, Szczapa J. Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznan region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies. J Clin Microbiol 2001;39:1912-16
9. Evengard B, Petterson K, Engman M-L, et al. Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 2001;127:121-7
10. Petersen E, Schmidt DR. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? Expert Rev Anti Infect Ther 2003;1:175-82
11. Gilbert R, Gras L. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. Br J Obstet Gynecol 2003;110:112-20
12. Thalib L, Gras L, Romand S, et al. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. Br J Obstet Gynecol 2005;112:567-74
13. Gras L, Wallon M, Pollak A, et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centers. Acta Paediatrica Scand 2005;94:1-2
14. Lebech M, Joynson DH, Seitz HM, et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Clin Microbiol Infect Dis 1996;15:799-805
15. Wallon M, Cozon G, Ecochard R, Lewin P, Peyron F. Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children. Eur J Pediatr 2001;160:534-40
16. Candolfi E, Bessieres MH, Marty P, et al. Determination of a new cut-off value for the diagnosis of congenital toxoplasmosis by detection of specific IgM in an enzyme immunoassay (letter). Eur J Clin Microbiol Infect Dis 1993;12:396-8
17. Pouletty P, Kadouche J, Garcia-Gonzalez M, et al. An anti-human mu chain monoclonal antibody: use for detection of IgM antibodies to Toxoplasma gondii by reverse immunosorbent assay. J Immunol Methods 1985;76:289-98
18. Pinon JM, Chemla C, Villena I, et al. Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J Clin Microbiol 1996;34:579-83
19. Decoster A, Lambert N, Germaneau C, Masson C. Toxoplasmosis serodiagnosis: comparison of Access Toxo IgM II assay compared to Axsym Toxo IgM and Vidas Toxo IgM assays. Ann Biol Clin (Paris) 2000;58:721-7
20. Decoster A, Lecolier B. Bicentric evaluation of Access Toxo immunoglobulin M (IgM) and IgG assays and IMx toxo IgM and IgG assays and comparison with Platelia Toxo IgM and IgG assays. J Clin Microbiol 1996;34:1606-9
21. Faure AK, Fricker-Hidalgo H, Pelloux H, Bost-Bru C, Goullier-Fleuret A, Ambroise-Thomas P. Lack of value of specific IgA detection in the postnatal diagnosis of congenital toxoplasmosis. J Clin Lab Anal 1999;13:27-30
22. Dunn D, Wallon M, Peyron F, Petersen E, Peckham CS, Gilbert RE. Mother to child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999;353:1829-33
23. Gleason JR. Improved confidence intervals for binomial proportions. STATA. STATA Tech Bull 1999;52:16-18
24. Wallon M, Dunn D, Slimani D, Girault V, Gay-Andrieu F, Peyron F. Diagnosis of congenital toxoplasmosis at birth: what is the value of testing for IgM and IgA? Eur J Pediatr 1999;158:645-9
25. Naessens A, Jenum PA, Pollak A, et al. Diagnosis of congenital toxoplasmosis in the neonatal period: a multicenter evaluation. J Pediatr 1999;135:714-19
26. Gras L, Gilbert RE, Wallon M, Peyron F, Cortina-Borja M. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect 2004;132:541-8
27. Binquet C, Wallon M, Metral P, Gadreau M, Quantin C, Peyron F. Toxoplasmosis seroconversion in pregnant women. The differing attitudes in France. Presse Med 2004;33:775-9
28. Pinon JM, Dumon H, Chemla C, et al. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 2001;39:2267-71
29. Nielsen HV, Schmidt DR, Petersen E. Diagnosis of congenital toxoplasmosis by two-dimensional immunoblot differentiation of mother and child immunoglobulin G profiles. J Gynecol Obstet Biol Reprod (Paris) 2005;43:711-15
30. Tissot DD, Fricker-Hidalgo H, Brenier-Pinchart MP, Bost-Bru C, Ambroise-Thomas P, Pelloux H. Usefulness of Western blot in serological follow-up of newborns suspected of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 2003;22:122-5
31. Fatoohi AF, Cozon GJ, Wallon M, et al. Cellular immunity to Toxoplasma gondii in congenitally infected newborns and immunocompetent infected hosts. Eur J Clin Microbiol Infect Dis 2003;22:181-4
32. Lebech M, Petersen E. Detection by enzyme immunosorbent assay of Toxoplasma gondii IgG antibodies in dried blood spots on PKU-filter paper from newborns. Scand J Infect Dis 1995;27:259-63
33. UK National Screening Committee. UK National Screening Committee criteria for appraising the viability, effectiveness and appropriateness of a screening programme. Accessed 21 June 2005.http://www.nsc.nhs.uk/uk_nsc/uk_nsc_ind.htm
34. Freeman K, Salt A, Prusa A, et al. Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns and impairments, in 3 year old children. Biomed Central Pediatrics 2005;5:23 doi:10.1186/1471-2431-5-23
35. Gras L, Gilbert RE, Ades AE, Dunn DT. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol 2001;30:1309-30
36. Wallon M, Kodjikian L, Binquet C, et al. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 2004;113:1567-1572
37. Gilbert RE, See SE, Jones LV, Stanford MR. Antibiotics for treating and preventing toxoplasma retinochoroiditis. The Cochrane Library 2002;(1):CD002218
38. Bahia-Oliveira LM, Jones JL, Azevedo-Silva J, Alves CC, Orefice F, Addiss DG. Highly endemic, waterborne toxoplasmosis in North Rio De Janeiro state, Brazil. Emerg Infect Dis 2003;9:55-62
39. Portela RW, Bethony J, Costa MI, et al. A multihousehold study reveals a positive correlation between age, severity of ocular toxoplasmosis, and levels of glycoinositolphospholipid-specific immunoglobulin A. J Infect Dis 2004;190:175-83
40. Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 2003;136:973- 88